NCT00216580View on ClinicalTrials.gov

A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis

PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 29, 2004

Study Completion Date

December 31, 2006

Conditions
Schizophrenia
Interventions
DRUG

Risperidone, long-acting injectable

All Listed Sponsors
lead

Janssen Pharmaceutica N.V., Belgium

INDUSTRY

NCT00216580 - A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis | Biotech Hunter | Biotech Hunter